BUD13 as a novel mediator of vascular endothelial dysfunction associated with type 2 diabetes

18 April 2026 (15:15 - 15:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Alvaro Santana Garrido

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail

Atrial tissue engineering using conditionally immortalized human myocytes: establishing matured and geometrically defined 3D models of atrial arrhythmias

Mr A. Nobacht (Leiden, NL)

Abstract Slides

Presentation thumbnail

The novel ErbB4 agonist JK07 modulates gene expression in key cardiac cells. insights from single-nuclei transcriptomics in a murine heart failure model

Miss C. Civati (Antwerp, BE)

Abstract Slides

Presentation thumbnail

Inhibition of dysregulated il-8-cxcr1 paracrine cellular crosstalk reverses cardiac hypertrophy and fibrosis in noonan syndrome

Mr F. Koitka (Goettingen, DE)

Abstract Slides

Presentation thumbnail

CSF2-driven myeloid reprogramming onnects metabolic stress to pulmonary vascular remodeling in HFpEF

Ms V. Masciovecchio (Zurich, CH)

Abstract Slides

Presentation thumbnail

Exploring cardiomyocytes-endothelial cell communication to promote cardiac revascularization and regeneration

Mrs F. Longo (Trieste, IT)

Abstract Slides

Access the full session

Session thumbnail

Young Investigators Award

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

18 April 2026 15:15 CET

You may be interested in

Congress Presentation

It is all about understanding the natural course: new thoughts about aortic disease

Congress Presentation

State-of-the-art lecture on vascular (dys)function in the failing heart

Congress Session

ESC William Harvey Lecture in Basic Science

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources